Leo Pharma

Type: Company
Name: Leo Pharma
Web Address: http://www.leo.se
First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Eurocom wins brief with Galderma

:03 in Marketing Services Eurocom Healthcare Communications has won a new contract with international dermatology company Galderma following a competitive pitch. The agency has been appointed to handle a range of the firm's consumer healthcare dermatology ... [Published Zenopa - Sep 01 2014]
First reported Aug 30 2014 - Updated Aug 30 2014 - 1 reports

Dorset County Show - visitors can check for skin damage at Know Your Skin stand

The Know Your Skin campaign greenhouse will be at the Dorset County Show on Saturday 6th and Sunday 7th September 8.30am-6pm and visitors will be able to learn how to check their skin for sun damage and obtain practical sun protection tips.LEO Pharma ... [Published Blackmore Vale Magazine - Aug 30 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Schreiner MediPharm wins supplier award from Leo Pharma

Read laterSchreiner MediPharm has been awarded Leo Pharma’s Best Supplier Award for 2013.Schreiner MediPharm supplies the internationally active pharmaceutical company with its Needle-Trap product, which is applied to heparin syringes to protect from ... [Published Labels and Labeling - Aug 26 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Schreiner MediPharm receives ‘Leo Best Supplier Award 2013’

Leo Pharma’s production site at Vernouillet, France, awarded the ‘Leo Best Supplier Award 2013’ to Schreiner MediPharm for its outstanding performance. Schreiner MediPharm supplies the internationally active pharmaceutical company with needle-trap, which ... [Published Express Pharma - Aug 21 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

New survey reveals Devon is struggling with staying safe in the sun

New survey results released today by LEO Pharma as part of the Know Your Skin campaign warn that Devon residents might have a dangerous lack of knowledge when it comes to keeping safe in the sun, and that they could be ignoring potential markers for an ... [Published This is the West Country - Aug 18 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 2 reports

TACLONEX (Calcipotriene And Betamethasone Dipropionate) Ointment [LEO Pharma Inc.]

First reported Aug 08 2014 - Updated Aug 08 2014 - 1 reports

Combination regimen safe, effective in treatment-naive myeloma

Induction and consolidation therapy with lenalidomide, bortezomib and dexamethasone, followed by 1 year of lenalidomide maintenance, appeared safe and effective in previously untreated patients with multiple myeloma, according to results of a phase 2 ... [Published Orthopedics Today - Aug 08 2014]
First reported Aug 01 2014 - Updated Aug 01 2014 - 1 reports

Schreiner MediPharm receives 'Leo Best Supplier Award 2013'

DetailsCategory: Latest UpdatesPublished on Friday, 01 August 2014 13:29Leo Pharma’s production site at Vernouillet, France, awarded the “Leo Best Supplier Award 2013” to Schreiner MediPharm for its outstanding performance. Schreiner MediPharm supplies ... [Published Express Pharma - Aug 01 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 1 reports

Schreiner Medipharm: Recognition as Outstanding Supplier

The pharmaceutical industry places high requirements on its suppliers, especially with regard to quality and delivery performance – this is also true for Leo Pharma. Schreiner MediPharm supplies the internationally active pharmaceutical company with Needle-Trap, ... [Published Packaging Europe - Jul 31 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 2 reports

Common Treatment for Pregnant Women May Be Ineffective

(dailyRx News) A common treatment for pregnant women prone to blood clots is a daily injection of blood thinner into the stomach. It's intended to prevent pregnancy complications, but recent research suggests this treatment may not work.New research from ... [Published Daily Rx - Jul 25 2014]
First reported Jul 15 2014 - Updated Jul 16 2014 - 1 reports

LEO Pharma & KLOX Technologies strike global dermatology deal

Dermatology leader LEO Pharma expands into acne, further pushing the boundaries of dermatology careKLOX gains access to global market, cementing its position as a leading Canadian life sciences specialty companyBALLERUP, Denmark and LAVAL, QC, July 15, ... [Published PR Newswire: Financial Services - Jul 15 2014]
First reported Mar 12 2014 - Updated Mar 12 2014 - 3 reports

Antares Pharma Receives Second Milestone Payment from LEO Pharma in OTREXUP Collaboration

EWING, N.J.--(EON: Enhanced Online News)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the receipt of a second milestone payment of $5 million from LEO Pharma. The milestone payment was received in connection with the launch of OTREXUP and the ... [Published EON Science - Mar 12 2014]

Quotes

...Tony Chant, managing director at Eurocom, said: "Galderma is a world leader in dermatology, so we are delighted to have been awarded the self-medication brands portfolio for the UK." The agency's other healthcare sector clients include major organisations such as Teva, Leo Pharma, ProStrakan, Smith and Nephew and Ferring Pharmace...
"The sun doesn’t discriminate so it’s important to be cautious all year round and watch out for signs of change to your skin, wherever you are and whatever the season, and to go and see your GP if you have any concerns.”"
...US back-up was evident in presentations from the Alliance for Healthcare Competitiveness, which "advocates for improved access to healthcare products and services across borders" , and numbers among its members the main US drug industry association, PhrMA, as well as companies including Abbott and Johnson and Johnson
In a meta-analysis, the Extracorporeal Treatments in Poisoning (EXTRIP) Workgroup concluded that "only long-acting barbiturate poisoning cases should be treated by ECTR and that the preferred mode of ECTR is hemodialysis" wrote lead author Dr...

More Content

All (37) | News (25) | Reports (0) | Blogs (11) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
Eurocom wins brief with Galderma [Published Zenopa - Sep 01 2014]
Dorset County Show - visitors can check for ski... [Published Blackmore Vale Magazine - Aug 30 2014]
Angiocrine Bioscience Licenses New Stem Cell Te... [Published Prlog - Aug 27 2014]
Schreiner MediPharm wins supplier award from Le... [Published Labels and Labeling - Aug 26 2014]
Acesion Pharma Appoints Ingelise Saunders As Ne... [Published BioSpace - Aug 25 2014]
Schreiner MediPharm receives ‘Leo Best Supplier... [Published Express Pharma - Aug 21 2014]
New survey reveals Devon is struggling with sta... [Published This is the West Country - Aug 18 2014]
TTIP: From Hot Tip to Oblivion? [Published Pharmaceutical Executive - Aug 18 2014]
TACLONEX (Calcipotriene And Betamethasone Dipro... [Published DailyMed Drug Label Updates for the last seven ... - Aug 12 2014]
TACLONEX (Calcipotriene And Betamethasone Dipro... [Published DailyMed Drug Label Updates for the last seven ... - Aug 12 2014]
Antares Pharma's (ATRS) CEO Paul Wotton on Q2 2... [Published Seeking Alpha - Aug 08 2014]
Combination regimen safe, effective in treatmen... [Published Orthopedics Today - Aug 08 2014]
Extracorporeal Treatment for Long-Acting Barbit... [Published General Medicine eJournal - Aug 07 2014]
Model N's (MODN) CEO Zack Rinat on Q3 2014 Resu... [Published Seeking Alpha - Aug 06 2014]
Schreiner MediPharm receives 'Leo Best Supplier... [Published Express Pharma - Aug 01 2014]
Healthcare, Pharma, Biotechnology, Medical Expe... [Published Prlog - Jul 31 2014]
Schreiner Medipharm: Recognition as Outstanding... [Published Packaging Europe - Jul 31 2014]
Antares Pharma to Host Second Quarter 2014 Oper... [Published Myrtle Beach Sun News - Jul 31 2014]
Thrombophilia of Pregnancy: Heparin Doesn’t Imp... [Published Diabetes Care - Jul 25 2014]
DLA Takes Life Science Partner From Hogan's Val... [Published Recorder - Jul 25 2014]
Common Treatment for Pregnant Women May Be Inef... [Published Daily Rx - Jul 25 2014]
LMWH did not reduce complications in pregnant w... [Published Orthopedics Today - Jul 25 2014]
LEO Pharma & KLOX Technologies strike global de... [Published PR Newswire: Financial Services - Jul 15 2014]
LEO Pharma & KLOX Technologies strike global de... [Published Financial Services - Jul 15 2014]
Dovobet ointment approved to treat psoriasis vu... [Published PBR - News - Jul 07 2014]
Antares Pharma Reports First Quarter 2014 Opera... [Published Business Wire Health News - May 09 2014]
Stop Paying Lip Service to Patient-Centricity [Published Pharmaceutical Executive - Apr 10 2014]
Perrigo launches generic Taclonex ointment to t... [Published PharmaBiz - Apr 03 2014]
Perrigo launches generic version of Taclonex oi... [Published PBR - News - Apr 02 2014]
PICATO (Ingenol Mebutate) Gel [LEO Pharma Inc.] [Published DailyMed Drug Label Updates for the last seven ... - Mar 24 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
TACLONEX (Calcipotriene And Betamethasone Dipro... [Published DailyMed Drug Label Updates for the last seven ... - Aug 12 2014]
Updated Date: Aug 11, 2014 EST ...
TACLONEX (Calcipotriene And Betamethasone Dipro... [Published DailyMed Drug Label Updates for the last seven ... - Aug 12 2014]
Updated Date: Aug 11, 2014 EST ...
LEO Pharma & KLOX Technologies strike global de... [Published PR Newswire: Financial Services - Jul 15 2014]
Dermatology leader LEO Pharma expands into acne, further pushing the boundaries of dermatology careKLOX gains access to global market, cementing its position as a leading Canadian life sciences specialty companyBALLERUP, Denmark and LAVAL, QC, July 15, ...
Dovobet ointment approved to treat psoriasis vu... [Published PBR - News - Jul 07 2014]
Kyowa Hakko Kirin Co., Ltd. (headquarters: Chiyoda-ku, Tokyo; President and CEO: Nobuo Hanai; "Kyowa Hakko Kirin") announced today that LEO Pharma K.K. (headquarters: Chiyoda-ku, Tokyo; General Manager and Japan Representative Director: Stefan Sakurai; ...
Antares Pharma Reports First Quarter 2014 Opera... [Published Business Wire Health News - May 09 2014]
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the first quarter ended March 31, 2014. Quarter and Recent Highlights Announced the product launch of OTREXUP™ (methotrexate) injection ...
1 2 3

Press Releases

sort by: Date | Relevance
LEO Pharma & KLOX Technologies strike global de... [Published Financial Services - Jul 15 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.